Pathol. Oncol. Res. Pathology & Oncology Research Pathol. Oncol. Res. 1532-2807 Frontiers Media S.A. 1609970 10.3389/pore.2021.1609970 Pathology and Oncology Archive Retraction Retraction: MiR-424-5p Inhibits Proliferation, Invasion and Promotes Apoptosis and Predicts Good Prognosis in Glioma by Directly Targeting BFAR Pathology & Oncology Research Editorial Office Retraction: MiR-424-5p Inhibits Proliferation, Invasion and Promotes Apoptosis and Predicts Good Prognosis in Glioma by Directly Targeting BFAR Pathology & Oncology Research Editorial Office * Frontiers Media SA, Lausanne, Switzerland *Correspondence: Pathology & Oncology Research Editorial Office, editorialoffice@por-journal.com 23 08 2021 2021 27 1609970 19 07 2021 19 07 2021 Copyright © 2021 Pathology & Oncology Research Editorial Office. 2021 Pathology & Oncology Research Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Retraction of the Original Research ArticleMiR-424-5p Inhibits Proliferation, Invasion and Promotes Apoptosis and Predicts Good Prognosis in Glioma by Directly Targeting BFARby Cheng, Z., Shu, H., Cui, Y., Zhang, Q., Zhao, B., Pan, D., Chao, Q., and Wang, D. (2020). MiR-424-5p Inhibits Proliferation, Invasion and Promotes Apoptosis and Predicts Good Prognosis in Glioma by Directly Targeting BFAR. Pathol. Oncol. Res. 26, 2327–2335. doi: 10.1007/s12253-020-00831-1

The journal and authors retract the article cited above for the following reasons provided by the authors:

The authors state “We cannot repeat some of the biological results of this article, which directly leads to our inability to carry out follow-up research. Based on the above objective reasons, after careful discussion and consideration, our team decided to withdraw the manuscript in a rigorous and scientific attitude”.

This retraction, as requested by the authors, was approved by the Editors-in-Chief of the Journal.